{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T17:54:40Z","timestamp":1755798880122,"version":"3.44.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,19]]},"DOI":"10.7759\/cureus.90496","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T15:34:49Z","timestamp":1755617689000},"source":"Crossref","is-referenced-by-count":0,"title":["Perioperative Considerations in a Patient With Oculopharyngeal Muscular Dystrophy: A Case Report"],"prefix":"10.7759","author":[{"given":"Pratima","family":"Bajaj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Overholt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamta","family":"Chura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2015.014","article-title":"Progress on gene therapy, cell therapy, and pharmacological strategies toward the treatment of oculopharyngeal muscular dystrophy","volume":"26","author":"Harish P","year":"2015","unstructured":"Harish P, Malerba A, Dickson G, Bachtarzi H. Progress on gene therapy, cell therapy, and pharmacological strategies toward the treatment of oculopharyngeal muscular dystrophy. Hum Gene Ther. 2015, 26:286-92. 10.1089\/hum.2015.014","journal-title":"Hum Gene Ther"},{"key":"ref2","article-title":"Oculopharyngeal muscular dystrophy","author":"Trollet C","year":"2001","unstructured":"Trollet C, Boulinguiez A, Roth F, et al.. Oculopharyngeal muscular dystrophy. GeneReviews\u00ae [Internet]. University of Washington, Seattle, Seattle (WA); 2001."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003554","article-title":"Correlation between PABPN1 genotype and disease severity in oculopharyngeal muscular dystrophy","volume":"88","author":"Richard P","year":"2017","unstructured":"Richard P, Trollet C, Stojkovic T, de Becdelievre A, Perie S, Pouget J, Eymard B. Correlation between PABPN1 genotype and disease severity in oculopharyngeal muscular dystrophy. Neurology. 2017, 88:359-65. 10.1212\/WNL.0000000000003554","journal-title":"Neurology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-022-02503-7","article-title":"Assessment of PABPN1 nuclear inclusions on a large cohort of patients and in a human xenograft model of oculopharyngeal muscular dystrophy","volume":"144","author":"Roth F","year":"2022","unstructured":"Roth F, Dhiab J, Boulinguiez A, et al.. Assessment of PABPN1 nuclear inclusions on a large cohort of patients and in a human xenograft model of oculopharyngeal muscular dystrophy. Acta Neuropathol. 2022, 144:1157-70. 10.1007\/s00401-022-02503-7","journal-title":"Acta Neuropathol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddz167","article-title":"Established PABPN1 intranuclear inclusions in OPMD muscle can be efficiently reversed by AAV-mediated knockdown and replacement of mutant expanded PABPN1","volume":"28","author":"Malerba A","year":"2019","unstructured":"Malerba A, Klein P, Lu-Nguyen N, et al.. Established PABPN1 intranuclear inclusions in OPMD muscle can be efficiently reversed by AAV-mediated knockdown and replacement of mutant expanded PABPN1. Hum Mol Genet. 2019, 28:3301-8. 10.1093\/hmg\/ddz167","journal-title":"Hum Mol Genet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/BF03022658","article-title":"Postoperative complications in patients with oculopharyngeal muscular dystrophy: a retrospective study","volume":"54","author":"Pellerin HG","year":"2007","unstructured":"Pellerin HG, Nicole PC, Tr\u00e9panier CA, Lessard MR. Postoperative complications in patients with oculopharyngeal muscular dystrophy: a retrospective study. Can J Anaesth. 2007, 54:361-5. 10.1007\/BF03022658","journal-title":"Can J Anaesth"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13102963","article-title":"Perioperative management in neuromuscular diseases: a narrative review","volume":"13","author":"Bhat A","year":"2024","unstructured":"Bhat A, Dean J, Aboussouan LS. Perioperative management in neuromuscular diseases: a narrative review. J Clin Med. 2024, 13:2963. 10.3390\/jcm13102963","journal-title":"J Clin Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s12630-022-02230-3","article-title":"Mapping the current evidence on the anesthetic management of adult patients with neuromuscular disorders\u2014a scoping review","volume":"69","author":"van den Bersselaar LR","year":"2022","unstructured":"van den Bersselaar LR, Gubbels M, Riazi S, Heytens L, Jungbluth H, Voermans NC, Snoeck MM. Mapping the current evidence on the anesthetic management of adult patients with neuromuscular disorders\u2014a scoping review. Can J Anaesth. 2022, 69:756-73. 10.1007\/s12630-022-02230-3","journal-title":"Can J Anaesth"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/mus.23817","article-title":"Neuromuscular disease and anesthesia","volume":"48","author":"Romero A","year":"2013","unstructured":"Romero A, Joshi GP. Neuromuscular disease and anesthesia. Muscle Nerve. 2013, 48:451-60. 10.1002\/mus.23817","journal-title":"Muscle Nerve"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/ACO.0000000000000466","article-title":"Anesthetic consideration for neuromuscular diseases","volume":"30","author":"Katz JA","year":"2017","unstructured":"Katz JA, Murphy GS. Anesthetic consideration for neuromuscular diseases. Curr Opin Anaesthesiol. 2017, 30:435-40. 10.1097\/ACO.0000000000000466","journal-title":"Curr Opin Anaesthesiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1378\/chest.120.6.2101","article-title":"Oculopharyngeal muscular dystrophy complicating airway management","volume":"120","author":"Christopher K","year":"2001","unstructured":"Christopher K, Horkan C, Patterson RB, Yodice PC. Oculopharyngeal muscular dystrophy complicating airway management. Chest. 2001, 120:2101-3. 10.1378\/chest.120.6.2101","journal-title":"Chest"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000012935","article-title":"Dysphagia with fatal choking in oculopharyngeal muscular dystrophy: case report","volume":"97","author":"Chen AW","year":"2018","unstructured":"Chen AW, Wu SL, Cheng WL, Chuang CS, Chen CH, Chen MK, Liu CS. Dysphagia with fatal choking in oculopharyngeal muscular dystrophy: case report. Medicine (Baltimore). 2018, 97:e12935. 10.1097\/MD.0000000000012935","journal-title":"Medicine (Baltimore)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/EJA.0000000000000672","article-title":"Anaesthetic management of patients with myopathies","volume":"34","author":"Schieren M","year":"2017","unstructured":"Schieren M, Defosse J, B\u00f6hmer A, Wappler F, Gerbershagen MU. Anaesthetic management of patients with myopathies. Eur J Anaesthesiol. 2017, 34:641-9. 10.1097\/EJA.0000000000000672","journal-title":"Eur J Anaesthesiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.945675","article-title":"A review of muscle relaxants in anesthesia in patients with neuromuscular disorders including Guillain-Barr\u00e9 syndrome, myasthenia gravis, Duchenne muscular dystrophy, Charcot-Marie-Tooth disease, and inflammatory myopathies","volume":"30","author":"Radkowski P","year":"2024","unstructured":"Radkowski P, Oniszczuk H, Opolska J, Podli\u0144ska I, Pawluczuk M, Onichimowski D. A review of muscle relaxants in anesthesia in patients with neuromuscular disorders including Guillain-Barr\u00e9 syndrome, myasthenia gravis, Duchenne muscular dystrophy, Charcot-Marie-Tooth disease, and inflammatory myopathies. Med Sci Monit. 2024, 30:e945675. 10.12659\/MSM.945675","journal-title":"Med Sci Monit"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000001409","article-title":"Current status of neuromuscular reversal and monitoring: challenges and opportunities","volume":"126","author":"Brull SJ","year":"2017","unstructured":"Brull SJ, Kopman AF. Current status of neuromuscular reversal and monitoring: challenges and opportunities. Anesthesiology. 2017, 126:173-90. 10.1097\/ALN.0000000000001409","journal-title":"Anesthesiology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/402119-perioperative-considerations-in-a-patient-with-oculopharyngeal-muscular-dystrophy-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T15:34:49Z","timestamp":1755617689000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/402119-perioperative-considerations-in-a-patient-with-oculopharyngeal-muscular-dystrophy-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,19]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.90496","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,8,19]]}}}